Trials / Completed
CompletedNCT04274647
Skin Sensitization Test (Modified Draize-95 Test)
Skin Sensitization Test (Modified Draize-95) to Support a Low Dermatitis Potential Claim
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 208 (actual)
- Sponsor
- YTY Industry (Manjung) Sdn Bhd · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Skin Sensitization Test (Modified Draize-95) to Support a Low Dermatitis Potential Claim for a Blue Non Sterile Powder Free Nitrile Examination Gloves. To evaluate whether residual chemical additives at a level that may induce type IV allergy in the unsensitized general user population are present in a finished rubber containing medical device.
Detailed description
1. To evaluate whether residual chemical additives at a level that may induce Type IV allergy in the unsensitized general user population are present in a finished rubber containing medical device. 2. To meet requirements for claim: This product demonstrated reduced potential for sensitizing users to chemical additives as described in Guidance for Industry and FDA Staff - Medical Glove Guidance Manual9. Supporting Test Data: A negative skin sensitization test (Modified Draize-95 Test) on a minimum of 200 non-sensitized human subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NON-STERILE, POWDER FREE NITRILE EXAMINATION GLOVES, LOW DERMATITIS POTENTIAL, TESTED FOR USE WITH CHEMOTHERAPY DRUGS - BLUE | Approximately 2cm x 2cm square positioned to ensure that the inside portion of the test material maintained skin contact. |
Timeline
- Start date
- 2019-09-10
- Primary completion
- 2020-02-04
- Completion
- 2020-02-12
- First posted
- 2020-02-18
- Last updated
- 2020-02-18
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT04274647. Inclusion in this directory is not an endorsement.